Pretreatment of CLL cells alone with OPN5 (no drug during coculture) was not sufficient to maintain OPN5’s effects on T cell differentiation, further implicating direct T cell effects of OPN5 treatment in addition to reduced CLL immunosuppressive signals (Supplemental Figure 12, E and F). Here, OPN5 is linked to B-cell chronic lymphocytic leukemia.